Antibiotics for acute pyelonephritis in children

Area of Science:

• Pediatrics
• Infectious Diseases
• Pharmacology

Background:

• Urinary tract infections (UTIs) are common in infants, with acute pyelonephritis being the most severe form.
• Acute pyelonephritis can lead to significant morbidity and potential permanent kidney damage in children.
• Current guidelines recommend initial intravenous (IV) followed by oral antibiotic therapy, but optimal duration remains unclear.

Purpose of the Study:

• To evaluate the benefits and harms of various antibiotic regimens for treating acute pyelonephritis in pediatric patients.
• To compare different antibiotic agents, routes of administration, frequencies, and durations of therapy.
• To inform evidence-based treatment strategies for pediatric acute pyelonephritis.

Main Methods:

• Systematic review and meta-analysis of randomized and quasi-randomized controlled trials.
• Searched multiple databases (CENTRAL, MEDLINE, EMBASE) without language restrictions up to December 2006.
• Included trials involving children aged 0-18 years with proven UTI and acute pyelonephritis; data extracted and analyzed using random effects models.

Main Results:

• No significant differences in persistent renal damage at 6 months or fever duration between oral therapy and IV followed by oral therapy.
• Similar outcomes for renal damage when comparing short-course IV therapy (3-4 days) with longer IV courses (7-14 days).
• No significant efficacy differences found between daily and thrice-daily aminoglycoside dosing.

Conclusions:

• Children with acute pyelonephritis can be effectively treated with oral antibiotics or short-course IV therapy followed by oral antibiotics.
• Single daily dosing of aminoglycosides is a safe and effective IV option.
• Further research is needed to establish the optimal total duration of antibiotic therapy for acute pyelonephritis.